Where did Walgreens go wrong?

The latest stories trending on MedCity News.

Editor's Pick

Top Story Walgreens to Be Acquired by Sycamore Partners: Where Did the Retail Giant Go Wrong? Walgreens is selling itself to the private equity firm Sycamore Partners. This comes after the company has faced increased competition from online retailers like Amazon. It remains to be seen, however, if Walgreens will perform better under Sycamore Partners. Sponsored Webinar: Using Automation to Streamline Healthcare Practice Workflows and Maximize Staff Effectiveness Presented by Jotform and MedCity News Join us this Thursday as we will discuss how health tech and healthcare practices approach data automation and how they can collaborate effectively. We'll also highlight: Improve time management and maximize healthcare practice productivity Create frictionless appointment scheduling  Improve patient retention and growth The webinar will also offer use cases with clinician and patient-facing examples Register Here.

Featured News

Beam Base Editor's Early Data in Rare Liver Disease Tee Up $500M Stock Sale in Tough Market Beam Therapeutics' first clinical data in the rare disease alpha-1 antitrypsin deficiency "set a bar for efficacy in the space," according to one analyst. But the ongoing market slide poses challenges for biotech companies aiming to raise money by selling stock. How Houston Methodist's ACO Reduced Its End-of-Life Spending by Nearly 20% Houston Methodist Coordinate Care is reducing costs through a partnership with Koda Health, a digital platform that guides patients through their end-of-life choices. Preliminary findings show the technology resulted in a 19% reduction in the total cost of care for patients at the end of their life, which equals nearly $9,000 in savings per patient. Novo Nordisk's Next-Gen Obesity Drug Disappoints Again With Lower Than Expected Weight Loss CagriSema, a dual-acting drug in development by Novo Nordisk, met the goal of a Phase 3 test in patients with obesity and type 2 diabetes. But the topline results don't show an advantage over Eli Lilly's commercialized obesity medication, Zepbound. When Dialysis Comes Home, Patients and Care Partners Flourish When home dialysis is done right, care partners quickly discover they are becoming an integral part of the process as engaged, informed participants rather than uninformed outside observers. By knowing more, care partners can worry a lot less. Harnessing Innovative Transplant Diagnostics to Improve Patient Outcomes Innovative transplant diagnostics and novel paradigms that give a clearer picture of a recipient's immune system at various phases of the transplant journey can enable transplant teams to mitigate some of these challenges and make more accurate and faster donor assessments, as well as more informed and patient-centric decisions post-transplant.

Video   Telehealth Can Be Easier Than You Think Dave Newman, chief medical officer of virtual care at Sanford Health, thinks that virtual care delivery is often more straightforward than people might think. For rural health systems like his, virtual care isn't just a "nice-to-have" — it's necessary to ensure patients are getting the care they need, he said.

Sponsored The 5 Best Software to Buy for Managing a Spa Franchise Presented by Meevo Choosing the right software translates directly into better client management, operational efficiency and growth for your spa franchise. Discover which tool is best for your business.  Learn More

Resources

MedCity Pivot Podcast: Being Clear About Cybersecurity A conversation with David Bardan, the general manager of the healthcare business at Clear, shows how the company is bringing its expertise to counter cybersecurity threats in the healthcare industry. Listen now

MedCity News • PO Box 901 • New York, NY unsubscribe